Ask an Expert

Question of the Day

Eric J. Nestler, M.D., Ph.D. - Brain & behavior research expert on depression
September 11, 2013

Several rapidly acting antidepressants are currently in clinical trial, such as ketamine (see 2011 Highlights, Dr. Zarate, on p.2). These rapidly acting agents have novel mechanisms compared to currently available antidepressants and could offer significant improvement to patients who do not fully respond to today's medications. In addition, efforts continue to identify even more antidepressant medications with novel mechanisms of action.


Eric J. Nestler, M.D., Ph.D.
Scientific Council Member
Nash Family Professor of Neuroscience
Chair, Department of Neuroscience
Director, Friedman Brain Institute
Mount Sinai School of Medicine

Husseini K. Manji, M.D.
Q What advice do you offer for comorbidity (diagnosed with more than one mental illness)?
A Many people have more than one official diagnosis in mental health, such... More >
Rachel G. Klein, Ph.D., Scientific Council Member, 1995 NARSAD Distinguished Investigator Grantee, 2004 Ruane Prize for Outstanding Achievement in Child & Adolescent Psychiatric Research, Professsor of Psychiatry, New York University Child Study Center, Expert on Childhood mental illnesses including ADHD and anxiety
Q In your time on the Scientific Council, what is the most promising area of brain and behavior research you’ve seen?
A Two areas appear most promising. One is that great progress has been made... More >